Christopher T. Coughlin, M.D. - Hematology/Oncology, Radiation Oncology

Dr. Coughlin is an internist specializing in cancer and diseases of the blood who has devoted much of his career to teaching, research, and writing. He is a radiation oncologist at Dartmouth-Hitchcock Medical Center in Lebanon, NH, and Professor of Medicine at Dartmouth Medical School.

Dr. Coughlin has served on the editorial board of the American Journal of Clinical Oncology since 1989. He is also a referee for the medical journals Cancer, Radiology, International Journal of Hyperthermia, and the International Journal of Radiation Oncology, Biology and Physics.

American Board of Internal Medicine - 1977

American Board of Internal Medicine, Medical Oncology - 1979

American Board of Internal Medicine, Hematology - 1980

American Board of Internal Medicine, Radiation Oncology - 1981

Folic Acid Deficiency Anemia

Hemochromatosis

Hemophilia

Iron Deficiency Anemia

Vitamin B-12 Deficiency Anemia

Von Willebrand Disease

M.D.: Harvard Medical School - 1973

Internship: Good Samaritan Hospital, Portland, OR, 1973 - 1974

Residency in Internal Medicine, Good Samaritan Hospital, Portland, OR, 1974 - 1976

Fellowship in Hematology, Montefiore Hospital, Bronx, NY, 1976 - 1977

Fellowship in Oncology, Montefiore Hospital, Bronx, NY, 1977 -1978

Fellowship in Radiotherapy, Montefiore Hospital, Bronx, NY, 1978 - 1980

Dartmouth Medical School:

• Assistant Professor of Clinical Medicine, 1980 - 1984
• Associate Professor of Clinical Medicine, 1984 - 1989
• Professor of Medicine, 1989 - present

Radiation Oncologist, Montefiore Hospital, Bronx, NY, 1979 - 1980

Dartmouth-Hitchcock Medical Center, Lebanon, NH:

• Radiation Oncologist, 1980 - present
• Director, Dept. of Radiation Oncology, April 1984 - February 1992

Associate Director for Radiation Oncology, Norris Cotton Cancer Center, Hanover, NH, April 1984 - February 1992

American Association for the Advancement of Science

American Cancer Society

American Federation of Clinical Research

American Medical Association

American Society of Clinical Oncology

American Society of Hematology

American Society of Therapeutic Radiology and Oncology

Institutional PI for Radiation Therapy Oncology Group

International Society for Stereotactic Radiosurgery

North America Hyperthermia Group

Radiation Research Society

Radium Society

1. Coughlin CT, Richmond RC, Page RL (1994). Platinum drug delivery and radiation for locally advanced prostate cancer. International Journal of Radiation Oncology, Biology and Physics 28: 1029 - 1038.
2. Ryan TP, Backus VL, Coughlin CT (1995). Large stationary microstrip arrays for superficial microwave hyperthermia at 433 MHz:SAR analysis and clinical data. International Journal of Hyperthermia 11(2): 187 - 209.
3. Pilepich MV, Caplan R, Byhardt RW, et al. (1997). Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 53-31. Journal of Clinical Oncology 15(3): 1013 - 1021.

This reviewer reported no financial conflicts.